Ocular Therapeutix (OCUL) Work In Process (2014 - 2026)

Ocular Therapeutix has reported Work In Process for 13 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process fell 31.19% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 31.19% YoY), and the FY2025 full-year result was $1.7 million, up 15.58% from the prior year.
• Work In Process for Q1 2026 stood at $1.2 million, down from $1.7 million in the prior quarter.
• The five-year high for Work In Process was $1.8 million in Q1 2025, with the low at $567000.0 in Q1 2022.
• Average Work In Process over 5 years is $1.1 million, with a median of $1.0 million recorded in 2023.
• Year-over-year, Work In Process soared 97.27% in 2025 and sank 31.19% in 2026.
• Tracing OCUL's Work In Process over 5 years: stood at $899000.0 in 2022, then grew by 12.57% to $1.0 million in 2023, then soared by 47.13% to $1.5 million in 2024, then rose by 15.58% to $1.7 million in 2025, then retreated by 27.83% to $1.2 million in 2026.
• The last three Work In Process figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison